Steven Gabardi

3.2k total citations
81 papers, 2.3k citations indexed

About

Steven Gabardi is a scholar working on Transplantation, Pediatrics, Perinatology and Child Health and Surgery. According to data from OpenAlex, Steven Gabardi has authored 81 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Transplantation, 24 papers in Pediatrics, Perinatology and Child Health and 22 papers in Surgery. Recurrent topics in Steven Gabardi's work include Renal Transplantation Outcomes and Treatments (41 papers), Pharmacological Effects and Toxicity Studies (15 papers) and Transplantation: Methods and Outcomes (12 papers). Steven Gabardi is often cited by papers focused on Renal Transplantation Outcomes and Treatments (41 papers), Pharmacological Effects and Toxicity Studies (15 papers) and Transplantation: Methods and Outcomes (12 papers). Steven Gabardi collaborates with scholars based in United States, Lebanon and Germany. Steven Gabardi's co-authors include Catherine Ulbricht, Ethan Basch, Anil Chandraker, Spencer T. Martin, Steven Baroletti, Stefan G. Tullius, Eric M. Tichy, Miae Kim, Stuart Abramson and Mónica Grafals and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Journal of the American Society of Nephrology and Journal of Physics Condensed Matter.

In The Last Decade

Steven Gabardi

80 papers receiving 2.2k citations

Peers

Steven Gabardi

TRANS

SURGE

EPIDE

ONCOL

Frederic Cofán Spain

Brenda C. M. de Winter Netherlands

Kearkiat Praditpornsilpa Thailand

Somchai Eiam‐Ong Thailand

Krister Höckerstedt Finland

A. Chmura Poland

Georges‐Philippe Pageaux France

Ali J. Olyaei United States

Mario Regazzi Italy

Graziella Zacchello Italy

Frederic Cofán Spain

Steven Gabardi

757 ×0.9

TRANS

542 ×1.2

SURGE

1.2k ×2.7

EPIDE

216 ×0.6

ONCOL

634 ×2.4

Citations per year, relative to Steven Gabardi Steven Gabardi (= 1×) peers Frederic Cofán

Countries citing papers authored by Steven Gabardi

Since Specialization

Citations

This map shows the geographic impact of Steven Gabardi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Gabardi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Gabardi more than expected).

Fields of papers citing papers by Steven Gabardi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Gabardi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Gabardi. The network helps show where Steven Gabardi may publish in the future.

Co-authorship network of co-authors of Steven Gabardi

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Gabardi. A scholar is included among the top collaborators of Steven Gabardi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Gabardi. Steven Gabardi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gabardi, Steven, et al.. (2023). Potential Effects of Remdesivir on Tacrolimus Exposure in Transplant Recipients With COVID-19 Infection. Kidney International Reports. 8(7). 1315–1322. 4 indexed citations

Gabardi, Steven. (2022). Immunosuppression in the Age of Precision Medicine. Seminars in Nephrology. 42(1). 86–98. 3 indexed citations

Gabardi, Steven & Teun van Gelder. (2017). Causes and Consequences of the Worldwide Belatacept Shortage. Transplantation. 101(7). 1520–1521. 10 indexed citations

Kim, Miae, Brian A. Bergmark, Thomas A. Zelniker, et al.. (2017). Early aspirin use and the development of cardiac allograft vasculopathy. The Journal of Heart and Lung Transplantation. 36(12). 1344–1349. 28 indexed citations

Mallat, Samir, Bassem Y. Tanios, Tamara Lotfi, et al.. (2017). CMV and BKPyV Infections in Renal Transplant Recipients Receiving an mTOR Inhibitor–Based Regimen Versus a CNI-Based Regimen: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials. Clinical Journal of the American Society of Nephrology. 12(8). 1321–1336. 82 indexed citations

Gabardi, Steven, et al.. (2016). Micafungin treatment and eradication of candiduria among hospitalized patients. International Urology and Nephrology. 48(11). 1881–1885. 20 indexed citations

Gabardi, Steven, et al.. (2016). Nephrotoxicity of Natural Products. Blood Purification. 41(1-3). 123–129. 27 indexed citations

Kim, Miae, Isabelle Wood, Steve Boukedes, et al.. (2014). Impact of Pretransplant Anti-HLA Antibodies on Outcomes in Lung Transplant Candidates. American Journal of Respiratory and Critical Care Medicine. 189(10). 1234–1239. 56 indexed citations

Riella, Leonardo V., Kassem Safa, Belinda Lee, et al.. (2014). Long-Term Outcomes of Kidney Transplantation Across a Positive Complement-Dependent Cytotoxicity Crossmatch. Transplantation. 97(12). 1247–1252. 38 indexed citations

10.

Martin, Spencer T., et al.. (2014). Hepatitis B Reactivation and Rituximab: A New Boxed Warning and Considerations for Solid Organ Transplantation. American Journal of Transplantation. 14(4). 788–796. 21 indexed citations

11.

Gabardi, Steven, et al.. (2013). Mycophenolate Fetal Toxicity and Risk Evaluation and Mitigation Strategies. American Journal of Transplantation. 13(6). 1383–1389. 60 indexed citations

12.

Gabardi, Steven, S. Caravati, Marco Bernasconi, & Michele Parrinello. (2012). Density functional simulations of Sb-rich GeSbTe phase change alloys. Journal of Physics Condensed Matter. 24(38). 385803–385803. 20 indexed citations

13.

Gabardi, Steven, et al.. (2011). Maintenance Immunosuppression with Intermittent Intravenous IL-2 Receptor Antibody Therapy in Renal Transplant Recipients. Annals of Pharmacotherapy. 45(9). 1163–1163. 5 indexed citations

14.

Martin, Spencer T., Sayeed K. Malek, Stefan G. Tullius, et al.. (2011). Induction Treatment with Rabbit Antithymocyte Globulin versus Basiliximab in Renal Transplant Recipients with Planned Early Steroid Withdrawal. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 31(6). 566–573. 18 indexed citations

15.

Martin, Spencer T., Eric M. Tichy, & Steven Gabardi. (2011). Belatacept: A Novel Biologic for Maintenance Immunosuppression After Renal Transplantation. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 31(4). 394–407. 26 indexed citations

16.

Gabardi, Steven. (2011). Understanding Risk Evaluation and Mitigation Strategies in Organ Transplantation. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 31(7). 714–722. 3 indexed citations

17.

Ensor, Christopher R., et al.. (2011). Generic Maintenance Immunosuppression in Solid Organ Transplant Recipients. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 31(11). 1111–1129. 40 indexed citations

18.

Gabardi, Steven & Stuart Abramson. (2005). Drug Dosing in Chronic Kidney Disease. Medical Clinics of North America. 89(3). 649–687. 61 indexed citations

19.

Winkelmayer, Wolfgang C., et al.. (2004). Pharmacoepidemiology of Anemia in Kidney Transplant Recipients. Journal of the American Society of Nephrology. 15(5). 1347–1352. 111 indexed citations

20.

Conort, Ornella, et al.. (2002). Intravenous to oral conversion of fluoroquinolones: knowledge versus clinical practice patterns.. Pharmacy World & Science. 24(2). 67–70. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact